Executive Moves | Healthcare | BioTuesdays by Kilmer Lucas IR

Executive Moves

Avalo appoints Dr. Rita Jain to BOD

Avalo Therapeutics (NASDAQ: AVTX) has announced the appointment of Rita Jain, MD, to its board of directors (BOD). To this role, Dr. Jain, a rheumatologist, brings more than two decades of leadership in...

June 18, 2025

Executive Moves

Beacon appoints Dr. Daniel Chung as CMO

Closely held Beacon Therapeutics announced the appointment of Dr. Daniel Chung as chief medical officer (CMO), effective immediately. Dr. Chung brings more than three decades of experience in ophthalmology, academic...

June 11, 2025

Executive Moves

Laura Conquergood joins Baylis as CEO

Closely held Baylis Medical Technologies announced the appointment of Laura Conquergood as chief executive officer (CEO). Kris Shah, formerly president and CEO, and Frank Baylis, formerly executive chairman, have both...

June 11, 2025

Executive Moves

BioRestorative welcomes renowned industry leader, Sandy Lipkins, to BRTX team

BioRestorative Therapies (NASDAQ: BRTX) announced the addition of serial regenerative medicine entrepreneur, company builder, and leader, Sandy Lipkins, to focus on technology commercialization and business development...

June 10, 2025

Executive Moves

FibroBiologics names Jason D. Davis as CFO

FibroBiologics (NASDAQ: FBLG) announced the appointment of Jason D. Davis, CPA, as chief financial officer (CFO), effective immediately. Bringing extensive experience in corporate finance, capital markets, and SEC...

June 9, 2025

Executive Moves

Dyadic announces leadership change as part of strategic shift

Dyadic International (NASDAQ: DYAI) announced that its board of directors has appointed Joe Hazelton as president, effective immediately, as part of an ongoing strategic shift to evolve into a revenue-generating...

June 2, 2025

Executive Moves

enGene appoints Amy Pott as chief global commercialization officer

enGene Holdings (NASDAQ: ENGN) announced the appointment of Amy Pott as chief global commercialization officer—the company’s first dedicated executive for commercialization endeavors—reporting to Ron Cooper, CEO of...

May 28, 2025

Executive Moves

CellCentric appoints Celia Economides as CFO & CBO

Closely held CellCentric has announced that it is expanding its leadership team with the appointment of Celia Economides as Chief Financial Officer & Chief Business Officer (CFO & CBO). According...

May 27, 2025

Executive Moves

Accomplished medtech industry veteran, Laurie Vertuccio, joins Profound Medical as VP of Global Marketing

Laurie Vertuccio has joined Profound Medical (NASDAQ:PROF; TSX:PRN) as Vice President of Global Marketing. The TULSA procedure, performed using Profound’s TULSA-PRO system, has the potential of becoming a mainstream...

May 27, 2025

Executive Moves

Scienture announces executive leadership transition

Scienture Holdings (NASDAQ: SCNX) announced that Suren Ajjarapu, CEO and chairman of the board, has stepped down. The management team of Dr. Shankar Hariharan and Dr. Narasimhan Mani will assume these roles. Shankar...

May 22, 2025

Executive Moves

Modivcare appoints Daniel Silvers to BOD; three BOD members resign

Modivcare (NASDAQ:MODV) announced that it has appointed Daniel Silvers to its board of directors (BOD), and board members Craig Barbarosh, David Coulter, and Richard Kerley have resigned, effective April 24, 2025. Mr...

April 25, 2025

Executive Moves

Verano names Richard Tarapchak as CFO

Verano Holdings (Cboe CA:VRNO; OTCQX:VRNOF) announced that it has promoted Richard Tarapchak to chief financial officer (CFO), succeeding Brett Summerer, who has resigned. Mr. Tarapchak brings more than 30 years of...

April 14, 2025

Executive Moves

Healthcare Integrated Technologies appoints Anand Ijju as CTO

Healthcare Integrated Technologies (OTC PINK: HITC) announced the appointment of Anand Ijju as chief technology officer (CTO). Mr. Ijju brings extensive experience in scaling global technology ventures, complemented by...

April 10, 2025

Executive Moves

Brian Donnelly joins Myriad as CCO

Myriad Genetics (NASDAQ:MYGN) announced it has appointed Brian Donnelly as chief commercial officer (CCO), effective May 1, 2025. Mr. Donnelly brings more than 20 years of leadership experience in healthcare...

April 8, 2025

Executive Moves

Telo appoints John Farlinger to BOD

Telo Genomics (TSXV:TELO) announced the appointment of John Farlinger to its board of directors (BOD) and will serve as chair of the company’s audit committee. With more than 30 years of experience in telecom...

April 4, 2025

Executive Moves

Leone Patterson joins Kalaris as BOD chair of audit committee

Kalaris Therapeutics (NASDAQ:KLRS) announced the appointment of Leone Patterson to its board of directors (BOD) as chair of the audit committee. Ms. Patterson brings extensive experience as a biotech executive and board...

April 4, 2025

Executive Moves

Laurie Glimcher joins ReAlta’s BOD

Closely held ReAlta Life Sciences has appointed immunologist Laurie Glimcher, MD, to its board of directors (BOD), effective immediately. Dr. Glimcher, widely renown for her work in cancer research, brings more than 35...

April 1, 2025

Executive Moves

Matinas names Keith Murphy and Edward Neugeboren to BOD

Matinas BioPharma (NYSE American:MTNB) has appointed biotech industry veterans Keith Murphy and Edward Neugeboren to its board of directors (BOD) as independent members, effective today. Also effective today, Matinas...

March 11, 2025

Executive Moves

Andrew Gengos joins Terns as CFO

Terns Pharmaceuticals (NASDAQ:TERN) has announced the appointment of Andrew Gengos as chief financial officer (CFO), effective immediately. Mr. Gengos brings 25 years of leadership experience in life sciences and...

February 25, 2025

Executive Moves

Industry vet John Calcagnini joins Mesirow as a managing director, healthcare sector

Mesirow Investment Banking has announced the appointment of John Calcagnini as a managing director in its investment banking group based in Los Angeles. Mr. Calgagnini will co-lead the company’s healthcare sector...

February 19, 2025

Executive Moves

Titan launches equity research division; names Boris Peaker senior healthcare analyst

Titan Partners Group, a division of American Capital Partners, has announced the launch of its equity research division with the appointment of Boris Peaker, Ph.D., CFA, as managing director and senior equity research...

February 11, 2025

Executive Moves

Therma Bright adds Steve Raysely to advisory board

Therma Bright (TSXV:THRM; OTCQB:TBRIF) has announced the appointment of Steve Raysely to its advisory board. Mr. Raysely brings senior executive expertise in healthcare technology sales, marketing, and operations to the...

February 4, 2025

Subscribe